Soreno: Siobhan McCrudden, a Psoriasis
oderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono's 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva). Serono officials say the study confirms the effectiveness and safety with continued use of Raptiva compared to placebo in patients who either continued after an initial 12-week therapy to receive treatment up to 24 weeks, or who received re-treatment for an additional 12 weeks following a treatment-free observation period.
Embed code for Blogs
Simply copy and paste the following HTML code below into your blog, website, or MySpace profile.
Copy to Clipboard
Share this video:
Simply click the button below and select your social bookmarking site.
Tag Cloud
Category: Health & Care
oderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono's 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva). Serono officials say the study...
Views: 8810















US Army: Parent Boost
National Institute on Drug Abuse: Game Plan Steroids
Chris Rock - Live Earth PSA
Star Wars Where Science Meets Imagination VNR
UNICEF - Yasminbi Faqueer India
UNICEF: With help from the Government of Japan, Southern Sudan rebuilds its schools
UNICEF: Gambia Mothers Clubs
Moore's Law Got Me
Economic Stimulus Plan
Get transit directions.
UNICEF - Queen Rania
World Food Program: Tsunami
General Motors: Fashion and Design
Volvo Cars' 80th Anniversary, Part 2
UNICEF: Floods in Indonesia
Intel International Science and Engineering Fair
UNICEF Yemen Children face the future Nutrition
UNICEF: Venezuela Indigenous Añu - Spanish
Ride Smarter Chicago Transit on Google Maps